DEFINING MECHANISTIC TARGETS AND CIRCULATING BIOMARKERS OF THERAPEUTIC RESPONSE AND RESISTANCE TO CLINICAL ATR AND CHK1 INHIBITORS IN HIGH-GRADE OVAR
$284,047FY2018Department of the ArmyDOD
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.